Jørgen Agnholt

VIP, Clinical Associate Professor

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jørgen Agnholt is a Clinical Associate Professor at Aarhus University in Denmark. His research focuses on immune-mediated inflammatory diseases, particularly the associations of genetic polymorphisms and treatment efficacy in various conditions such as Crohn’s disease. Recent publications highlight his work on therapeutic interventions and inflammatory responses in relation to gastrointestinal disorders.

Articles (10)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Associate professor

Göteborgs Universitet

SWEDEN

View details

Kasper Fjellhaugen Hjuler

Aarhus University Hospital

DENMARK

Aarhus University Hospital

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jørgen Agnholt

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Exploring associations of single nucleotide polymorphisms in ERAP1 and ERAP2 with susceptibility to multiple immune-mediated inflammatory diseases

Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn’s disease

Efficacy of Injection of Freshly Collected Autologous Adipose Tissue into Complex Cryptoglandular Anal Fistulas

Fecal Supernatants from Patients with Crohn’s Disease Induce Inflammatory Alterations in M2 Macrophages and Fibroblasts

Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor‐induced colitis

Motorized spiral enteroscopy

Casein glycomacropeptide is well tolerated in healthy adults and changes neither high-sensitive C-reactive protein, gut microbiota nor faecal butyrate

Effectiveness of interdisciplinary combined dermatology–gastroenterology–rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a parallel group, non-blinded, pragmatic randomised trial

Effectiveness of infliximab treatment of complex idiopathic anal fistulas

Seven weeks of high-dose Vitamin D treatment reduces the need for infliximab dose-escalation and decreases inflammatory markers in Crohn’s disease during one-year follow-up

Collaborators (12)

Anne Gitte Loft

Pedersen Bodil Ginnerup

Claus Johansen

Martin Iain Bahl

Bent Deleuran

Line Reinert

Maria Magnusson

Kasper Fjellhaugen Hjuler

Lena Öhman

Andreas Nordholm-Carstensen

Jacob Bjerrum

Trine Bertelsen

Make your next move.